Infusion devices and related rescue detection methods

    公开(公告)号:US10117992B2

    公开(公告)日:2018-11-06

    申请号:US15096156

    申请日:2016-04-11

    Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device to deliver fluid to a body of a user involves obtaining measurement values for a physiological condition influenced by the fluid, autonomously operating the infusion device to deliver the fluid based at least in part on the measurement values, and detecting a nonactionable condition based on the measurement values. In response to detecting the nonactionable condition, delivery of the fluid is limited while maintaining autonomous operation of the infusion device. In one exemplary embodiment, the nonactionable condition is a rescue condition indicative of the user having consumed fast-acting carbohydrates, and thus insulin delivery may be automatically limited in response to detecting the rescue carbohydrate consumption.

    SENSOR MODEL SUPERVISOR FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM
    16.
    发明申请
    SENSOR MODEL SUPERVISOR FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM 审中-公开
    用于闭环胰岛素输注系统的传感器模型监护仪

    公开(公告)号:US20160256629A1

    公开(公告)日:2016-09-08

    申请号:US15138540

    申请日:2016-04-26

    Abstract: An insulin infusion device includes a processor architecture, and a memory element that stores executable instructions to perform a method of controlling delivery of insulin to a user. The method operates the device in a closed-loop mode to deliver insulin, obtains patient-specific parameters for a current time sample, and estimates a plasma insulin value and a blood glucose value for the user based on at least some of the patient-specific parameters. The estimating is also based on a previously estimated plasma insulin value obtained for a previous time sample, and a previously estimated blood glucose value obtained for the previous time sample. A predicted sensor glucose value is generated for the current time sample, and the closed-loop mode or a safe basal mode is selected for controlling operation of the insulin infusion device in accordance with the selected mode.

    Abstract translation: 胰岛素输注装置包括处理器架构和存储可执行指令的存储器元件,以执行控制向用户传送胰岛素的方法。 所述方法以闭环模式操作所述装置以递送胰岛素,获取当前时间样本的患者特异性参数,并且基于所述患者特异性的至少一些来估计用户的血浆胰岛素值和血糖值 参数。 估计还基于对于先前时间样本获得的先前估计的血浆胰岛素值和对于先前时间样本获得的先前估计的血糖值。 为当前时间样本生成预测的传感器葡萄糖值,并且根据所选择的模式选择闭环模式或安全基础模式以控制胰岛素输注装置的操作。

    GENERATION AND APPLICATION OF AN INSULIN LIMIT FOR A CLOSED-LOOP OPERATING MODE OF AN INSULIN INFUSION SYSTEM
    17.
    发明申请
    GENERATION AND APPLICATION OF AN INSULIN LIMIT FOR A CLOSED-LOOP OPERATING MODE OF AN INSULIN INFUSION SYSTEM 有权
    胰岛素灌注系统闭环操作模式胰岛素限制的产生与应用

    公开(公告)号:US20140066889A1

    公开(公告)日:2014-03-06

    申请号:US13966120

    申请日:2013-08-13

    Abstract: A controller for an insulin infusion device includes a processor device and a memory element that cooperate to provide a processor-implemented closed-loop insulin limit module. The insulin limit module is operated to obtain: a fasting blood glucose value of a user; a total daily insulin value of the user; and fasting insulin delivery data that is indicative of insulin delivered to the user during a fasting period. The insulin limit module calculates a maximum insulin infusion rate for the user based on the fasting blood glucose value, the total daily insulin value, and the fasting insulin delivery data. The maximum insulin infusion rate is applicable during a period of closed-loop operation of the insulin infusion device.

    Abstract translation: 用于胰岛素输注装置的控制器包括处理器装置和协作提供处理器实现的闭环胰岛素限制模块的存储元件。 操作胰岛素限制模块以获得用户的空腹血糖值; 用户的每日总胰岛素值; 以及空腹胰岛素递送数据,其指示在空腹期间递送给用户的胰岛素。 胰岛素限制模块基于空腹血糖值,总日胰岛素值和空腹胰岛素递送数据计算用户的最大胰岛素输注速率。 在胰岛素输注装置的闭环操作期间,最大胰岛素输注速率是适用的。

    SENSOR MODEL SUPERVISOR FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM
    18.
    发明申请
    SENSOR MODEL SUPERVISOR FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM 审中-公开
    用于闭环胰岛素输注系统的传感器模型监护仪

    公开(公告)号:US20140066884A1

    公开(公告)日:2014-03-06

    申请号:US13870907

    申请日:2013-04-25

    Abstract: An electronic device includes a processor architecture and a memory element that stores instructions that, when executed by the processor architecture, perform a method of controlling an insulin infusion device for a user. The method operates the device in a closed-loop mode to deliver insulin to the user, obtains current insulin-delivered data and current glucose sensor data for the user, and processes historical insulin-delivered data and historical sensor data, to obtain predicted sensor glucose values for a historical time period. The method continues by calculating a difference between the current sensor glucose value and a predicted current sensor glucose value for the most recent sampling period. An alert is generated when the difference exceeds a threshold error amount.

    Abstract translation: 电子设备包括处理器架构和存储元件,存储元件存储当由处理器架构执行时执行用于使用者控制胰岛素输注装置的方法的指令。 该方法以闭环模式操作设备以将胰岛素输送给用户,获得用户当前的胰岛素递送数据和当前葡萄糖传感器数据,并处理历史胰岛素递送数据和历史传感器数据,以获得预测的传感器葡萄糖 历史时期的价值观。 该方法通过计算当前传感器葡萄糖值与最近采样周期的预测电流传感器葡萄糖值之间的差异来继续。 当差超过阈值误差量时,产生警报。

    Determination of adjustments to fluid delivery settings

    公开(公告)号:US12144966B2

    公开(公告)日:2024-11-19

    申请号:US17541673

    申请日:2021-12-03

    Abstract: Disclosed are techniques related to determination of adjustments to fluid delivery settings. The techniques may involve accessing an input meal size category, where the input meal size category is selected from among a plurality of meal size categories via a user interface; accessing a plurality of groups of historical meal events for a person, where each group of the plurality of groups is associated with a respective meal size category of the plurality of meal size categories and includes respective historical meal events for the person categorized in the respective meal size category; identifying a group, in the plurality of groups of historical meal events for the person, having an associated meal size category that matches the input meal size category; identifying a person-specific carbohydrate amount representative of the historical meal events in the identified group; and determining a bolus dosage value of insulin based on the person-specific carbohydrate amount.

Patent Agency Ranking